Schneider_2017_Neurodegener.Dis.Manag_7_365

Reference

Title : Parkinson's disease psychosis: presentation, diagnosis and management - Schneider_2017_Neurodegener.Dis.Manag_7_365
Author(s) : Schneider RB , Iourinets J , Richard IH
Ref : Neurodegener Dis Manag , 7 :365 , 2017
Abstract :

Parkinson's disease is a neurodegenerative disorder characterized by motor and nonmotor symptoms. Psychosis is a common feature of Parkinson's disease. Parkinson's disease psychosis (PDP) encompasses minor phenomena (illusions, passage hallucinations and presence hallucinations), visual and nonvisual hallucinations and delusions. PDP is associated with reduced function and quality of life. The initial management approach should focus on identification and treatment of any contributory medical factors, reduction or discontinuation of medications with potential to induce or worsen psychosis, nonpharmacological strategies and consideration of acetylcholinesterase inhibitor treatment in the setting of dementia. Pimavanserin, quetiapine and clozapine may all be considered for use in PDP. In this review, we discuss the presentation, diagnosis and management of PDP.

PubMedSearch : Schneider_2017_Neurodegener.Dis.Manag_7_365
PubMedID: 29160144

Related information

Citations formats

Schneider RB, Iourinets J, Richard IH (2017)
Parkinson's disease psychosis: presentation, diagnosis and management
Neurodegener Dis Manag 7 :365

Schneider RB, Iourinets J, Richard IH (2017)
Neurodegener Dis Manag 7 :365